NCT05356091 is a NA clinical trial of Sevoflurane in Quality of Recovery, sponsored by Kangbuk Samsung Hospital.

Who is sponsoring NCT05356091?

NCT05356091 is sponsored by Kangbuk Samsung Hospital.

What drugs are being tested in NCT05356091?

Interventions in NCT05356091: Sevoflurane, Remimazolam.

What condition does NCT05356091 study?

NCT05356091 studies Quality of Recovery.

Is NCT05356091 still recruiting?

NCT05356091 is currently completed. Last updated 9 March 2023.

Last reviewed 2023-03-09 · How we verify

NCT05356091

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.

Completed NA Last updated 9 March 2023

What this trial tests

NA trial testing Sevoflurane in Quality of Recovery in 36 participants. Completed in 24 February 2023.

Timeline

2 December 2022

Primary endpoint
24 February 2023

24 February 2023

Quick facts

Lead sponsor	Kangbuk Samsung Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	36
Start date	2 December 2022
Primary completion	24 February 2023
Estimated completion	24 February 2023
Sites	1 location across South Korea

Drugs / interventions tested

Sevoflurane — full drug profile →
Remimazolam — full drug profile →

Conditions studied

Quality of Recovery — all drugs for Quality of Recovery →

Sponsor

Kangbuk Samsung Hospital

Who can join

19 and older, any sex, with Quality of Recovery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designated to investigate the quality of recovery after transurethral bladder resection. Because, patients undergoing transurethral bladder resection are mostly old age, and because of catheter-related bladder discomfort are common after transurethral bladder resection, study on the quality of recovery after transurethral bladder resection seems to be meaningful. In general, sevoflurane is commonly used as an anesthetic agent for general anesthesia of transurethral bladder resection. The purpose of this study is to investigate whether remimazolam is not inferior to sevoflurnane in terms of quality of recovery after transurethral bladder resection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparative study on the impact of remimazolam and sevoflurane on quality of recovery after transurethral resection of bladder tumor: A randomized controlled noninferiority study.
Ryu KH, Lee SH, Shim JG, Park J, et al · · 2024 · cited 6× · PMID 39093727 · DOI 10.1097/md.0000000000038962

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

NCT07525648 — Comparison of the Effects of Sevoflurane and Desflurane on Optic Nerve Sheath Diameter During Laparoscopic Surgery · NA · recruiting
NCT07511634 — Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Cont · NA · not yet recruiting
NCT07440758 — Low-Flow Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy · NA · not yet recruiting
NCT07295158 — Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy · NA · recruiting
NCT07152912 — Impact of Isoflurane and Sevoflurane on Oxidative Stress in Patients Undergoing Laparoscopic Cholecystectomy · NA · recruiting

Other recruiting trials for Quality of Recovery

Currently open trials in the same condition.

NCT06584825 — Enhanced Vitals Monitoring After Major Surgery Trial · NA · recruiting
NCT06948383 — SPSIPB vs. SAPB in Breast Surgery · NA · active not recruiting

Other Kangbuk Samsung Hospital trials

Trials by the same sponsor.

NCT07396961 — Consistency of ASIS Line vs. Tuffier's Line for Lumbar Level Identification · not yet recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT06773585 — Investigations of Factors Associated With Treatment Response and Prognosis in Anxiety Disorders · not yet recruiting
NCT06130137 — Gut Microbiome in People Living With HIV and HBV · not yet recruiting
NCT05538741 — Hypotension After Anesthetic Induction with Remimazolam in Elderly · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05356091 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kangbuk Samsung Hospital
Last refreshed: 9 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05356091.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing